Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MBX Biosciences (MBX) Cash from Operations (2023 - 2026)

MBX Biosciences has reported Cash from Operations over the past 4 years, most recently at 20208000.0 for Q1 2026.

  • Quarterly results put Cash from Operations at 20208000.0 for Q1 2026, up 10.89% from a year ago — trailing twelve months through Mar 2026 was 77479000.0 (down 16.25% YoY), and the annual figure for FY2025 was 79949000.0, down 46.21%.
  • Cash from Operations reached 20208000.0 in Q1 2026 per MBX's latest filing, down from 18301000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 10710000.0 in Q1 2024 and bottomed at 22678000.0 in Q1 2025.
  • Median Cash from Operations over the past 4 years was 16735500.0 (2024), compared with a mean of 16598400.0.
  • The largest annual shift saw Cash from Operations tumbled 111.75% in 2025 before it grew 10.89% in 2026.
  • Over 4 years, Cash from Operations stood at 11146000.0 in 2023, then tumbled by 43.88% to 16037000.0 in 2024, then dropped by 14.12% to 18301000.0 in 2025, then dropped by 10.42% to 20208000.0 in 2026.
  • Business Quant data shows Cash from Operations for MBX at 20208000.0 in Q1 2026, 18301000.0 in Q4 2025, and 21536000.0 in Q3 2025.